Argenx
ARGX
#568
Rank
A$56.46 B
Marketcap
$941.53
Share price
-1.02%
Change (1 day)
37.13%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : A$6.56 Billion

According to Argenx 's latest financial reports the company has A$6.56 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$A$4.13 B18.28%
2021-12-31$A$3.49 B30.54%
2020-12-31$A$2.67 B41.78%
2019-12-31$A$1.88 B88.84%
2018-12-31$A$1.00 B57.25%
2017-12-31$A$0.63 B553.91%
2016-12-31$A$97.25 M58.99%
2015-12-31$A$61.17 M-32.41%
2014-12-31$A$90.5 M95.03%
2013-12-31$A$46.4 M118.93%
2012-12-31$A$21.19 M-40.02%
2011-12-31$A$35.33 M163.71%
2010-12-31$A$13.39 M